BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10668936)

  • 1. Glycosaminoglycans excretion in interstitial cystitis.
    Akçay T; Konukoğlu D
    Int Urol Nephrol; 1999; 31(4):431-5. PubMed ID: 10668936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of elevated urinary total to sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis.
    Wei DC; Politano VA; Selzer MG; Lokeshwar VB
    J Urol; 2000 May; 163(5):1577-83. PubMed ID: 10751891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis.
    Soler R; Bruschini H; Truzzi JC; Martins JR; Camara NO; Alves MT; Leite KR; Nader HB; Srougi M; Ortiz V
    Int Braz J Urol; 2008; 34(4):503-11; discussion 511. PubMed ID: 18778502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased urine glycosaminoglycan excretion in cats with interstitial cystitis.
    Buffington CA; Blaisdell JL; Binns SP; Woodworth BE
    J Urol; 1996 May; 155(5):1801-4. PubMed ID: 8627887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary uronate and sulfated glycosaminoglycan levels: markers for interstitial cystitis severity.
    Lokeshwar VB; Selzer MG; Cerwinka WH; Gomez MF; Kester RR; Bejany DE; Gousse AE
    J Urol; 2005 Jul; 174(1):344-9. PubMed ID: 15947687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.
    Erickson DR; Ordille S; Martin A; Bhavanandan VP
    J Urol; 1997 Jan; 157(1):61-4. PubMed ID: 8976216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity.
    Lokeshwar VB; Selzer MG; Unwala DJ; Estrella V; Gomez MF; Golshani R; Kester RR; Klumpp DJ; Gousse AE
    J Urol; 2006 Sep; 176(3):1001-7. PubMed ID: 16890679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis.
    Kuo HC
    Int J Urol; 2014 Apr; 21 Suppl 1():34-41. PubMed ID: 24807491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the metabolism of glycosaminoglycans in patients with interstitial cystis.
    Lucon M; Martins JR; Leite KR; Soler R; Nader HB; Srougi M; Bruschini H
    Int Braz J Urol; 2014; 40(1):72-9. PubMed ID: 24642152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis.
    Bouchelouche K; Kristensen B; Nordling J; Horn T; Bouchelouche P
    J Urol; 2001 Dec; 166(6):2121-5. PubMed ID: 11696719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects.
    Maccari F; Buzzega D; Galeotti F; Volpi N
    Int Urogynecol J; 2011 Dec; 22(12):1581-6. PubMed ID: 21809155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ls clinical practice aligned with the latest scientific evidence on GAG therapy?
    Janssen DAW
    Urologia; 2017 Sep; 84(Suppl 1):16-20. PubMed ID: 28862729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased urinary uronic acid levels in individuals with interstitial cystitis.
    Parsons CL; Hurst RE
    J Urol; 1990 Apr; 143(4):690-3. PubMed ID: 2313793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urinary excretion of leukotriene E(4) in patients with interstitial cystitis.
    Bouchelouche K; Kristensen B; Nordling J; Horn T; Larsen S; Hald T; Bouchelouche P
    Urology; 2001 Jun; 57(6 Suppl 1):128. PubMed ID: 11378123
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated urinary levels and urothelial expression of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein in patients with interstitial cystitis.
    Makino T; Kawashima H; Konishi H; Nakatani T; Kiyama H
    Urology; 2010 Apr; 75(4):933-7. PubMed ID: 19646740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stretch-activated release of adenosine triphosphate by bladder uroepithelia is augmented in interstitial cystitis.
    Sun Y; Keay S; DeDeyne P; Chai T
    Urology; 2001 Jun; 57(6 Suppl 1):131. PubMed ID: 11378132
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of the kallikrein kinin system in interstitial cystitis.
    Rosamilia A; Clements JA; Dwyer PL; Kende M; Campbell DJ
    J Urol; 1999 Jul; 162(1):129-34. PubMed ID: 10379755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary glycosaminoglycan excretion as a laboratory marker in the diagnosis of interstitial cystitis.
    Hurst RE; Parsons CL; Roy JB; Young JL
    J Urol; 1993 Jan; 149(1):31-5. PubMed ID: 8417212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased excretion of urine glycosaminoglycans as marker in renal amyloidosis.
    Tencer J; Torffvit O; Grubb A; Björnsson S; Thysell H; Rippe B
    Nephrol Dial Transplant; 1997 Jun; 12(6):1161-6. PubMed ID: 9198045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary glycosaminoglycan excretion in urolithiasis.
    Akçay T; Konukoğlu D; Dínçer Y
    Arch Dis Child; 1999 Mar; 80(3):271-2. PubMed ID: 10325710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.